Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls:: Concomitant assessment of perforin, IFN-γ and IL-4 secretion

被引:12
作者
Burton, CT [1 ]
Gotch, F [1 ]
Imami, N [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London SW10 9NH, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
lymphocyte responses; highly active antiretroviral therapy (HAART); interferon gamma; perforin; interleukin-4; T-cell memory; T-cell anergy;
D O I
10.1016/j.jim.2005.11.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The enzyme-linked inummospot (ELIspot) assay is a highly sensitive and valuable tool for determining the frequency of cytokine-secreting T cells. It is essential to determine both frequencies and functional capabilities of antigen-specific T cells, including cytokine secretion, degranulation, and cytotoxicity in order to obtain a faller picture of the immune status of an individual. We describe here for the first time a perforin-release ELIspot assay which, when used in combination with IFN-gamma and IL-4 ELIspots, permits rapid assessment of these functional parameters for antigen-specific T cells. Whole antigen or peptides from HIV-1, recall and other viral antigens were used for in vitro stimulation. Anti-HIV-1 responses in treated chronically infected individuals were weak, both in terms of perform and IFN-gamma production. Tetanus toxoid stimulation was associated with moderate perforin release and a predominantly type-2 IL-4 producing response, whilst herpes simplex virus antigen stimulation resulted in perforin release but only a weak type-1 IFN-gamma response. Anti-cytomegalovirus responses generated high levels of perform in conjunction with IFN-gamma. Cytokines IL-2 and IL-12/IL-15 induced perform release coupled with an IFN-gamma type-1 response. Perform release strongly correlated with IFN-gamma production to individual influenza, Epstein-Barr virus or cytomegalovirus MHC class I restricted peptides, in an HIV-1 sero-negative cohort, indicating a cytolytic type-1 CD8(+) T-cell response. Evaluation of immunogenicity and putative efficacy of candidate vaccines using IFN-gamma will not be as informative alone as when combined with perforin and IL-4 evaluations, which allow assessment of specific cytotoxic potential without extensive cell culture. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:216 / 230
页数:15
相关论文
共 34 条
  • [1] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [2] HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
    Appay, V
    Nixon, DF
    Donahoe, SM
    Gillespie, GMA
    Dong, T
    King, A
    Ogg, GS
    Spiegel, HML
    Conlon, C
    Spina, CA
    Havlir, DV
    Richman, DD
    Waters, A
    Easterbrook, P
    McMichael, AJ
    Rowland-Jones, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) : 63 - 75
  • [3] Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with ≤250/μL CD4 T cells and undetectable plasma virus load
    Arnó, A
    Ruiz, L
    Juan, M
    Jou, A
    Balagué, M
    Zayat, MK
    Marfil, S
    Martínez-Picado, J
    Martínez, MA
    Romeu, J
    Pujol-Borrell, R
    Lane, C
    Clotet, B
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) : 56 - 60
  • [4] Restoration of the immune system with anti-retroviral therapy
    Autran, B
    Carcelaint, G
    Li, TS
    Gorochov, G
    Blanc, C
    Renaud, M
    Durali, M
    Mathez, D
    Calvez, V
    Leibowitch, J
    Katlama, C
    Debré, P
    [J]. IMMUNOLOGY LETTERS, 1999, 66 (1-3) : 207 - 211
  • [5] Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
    Betts, MR
    Brenchley, JM
    Price, DA
    De Rosa, SC
    Douek, DC
    Roederer, M
    Koup, RA
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 281 (1-2) : 65 - 78
  • [6] BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
  • [7] Skewed maturation of memory HIV-specific CD8 T lymphocytes
    Champagne, P
    Ogg, GS
    King, AS
    Knabenhans, C
    Ellefsen, K
    Nobile, M
    Appay, V
    Rizzardi, GP
    Fleury, S
    Lipp, M
    Förster, R
    Rowland-Jones, S
    Sékaly, RP
    McMichael, AJ
    Pantaleo, G
    [J]. NATURE, 2001, 410 (6824) : 106 - 111
  • [8] A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION
    CLERICI, M
    SHEARER, GM
    [J]. IMMUNOLOGY TODAY, 1993, 14 (03): : 107 - 110
  • [9] A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
    Currier, JR
    Kuta, EG
    Turk, E
    Earhart, LB
    Loomis-Price, L
    Janetzki, S
    Ferrari, G
    Birx, DL
    Cox, JH
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) : 157 - 172
  • [10] Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy - A randomized controlled trial
    Davey, RT
    Murphy, RL
    Graziano, FM
    Boswell, SL
    Pavia, AT
    Cancio, M
    Nadler, JP
    Chaitt, DG
    Dewar, RL
    Sahner, DK
    Duliege, AM
    Capra, WB
    Leong, WP
    Giedlin, MA
    Lane, HC
    Kahn, JO
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02): : 183 - 189